Description
Peptide Complex for women during menopause.
Release form: Pack of 30 capsules.
The capsule is produced from a special stable polymer of a plant origin — hypromellose- without chemical impurities.
The multicomponent peptide complex MenoTIDE PLUS is a safe, non-hormonal natural product that helps regulate hormonal levels, improve the physical and emotional state of a woman during menopause (one year after the last menstruation).
The ovaries not only produce eggs but also secrete hormones — mainly estrogen and progesterone. During the perimenopause period and menopause, levels of these hormones drop, causing many uncomfortable physical changes, including hot flashes and excessive sweating, sleep problems, mood changes, vaginal dryness or atrophy, urinary incontinence, osteoporosis, nervousness, and heart palpitations.
Natural peptide complex MenoTIDE PLUS supports the female reproductive system and healthy hormonal balance during menopause, provides a selective effect on cells of the reproductive system, accelerates cellular repair processes, and improves ovarian functions. Peptides produce protein synthesis and restore damaged cells, they get into the blood through the gastrointestinal tract.
Peptide bioregulator regulates estrogen and progesterone metabolism in ovaries, eliminates disorders caused by menopause, and prevents the development of serious diseases. The formula of the peptide bioregulator is intensified with minerals, vitamins, herbal extracts that support a healthy body’s response to the natural changes that occur during menopause and nourish the intercellular space of the reproductive organs.
Vitamin C is the most important natural antioxidant that protects the intercellular space.
Vitamin E provides intracellular antioxidant protection.
Zinc is essential for muscle growth and repair, strengthens the immune system and regulates production of hormones.
Vitamin A provides cell membrane with antioxidant protection and integrality.
Red clover extract is aimed at eliminating estrogen deficiency, replenishing hormonal insufficiency, reducing the likelihood of developing estrogen-dependent symptoms during menopause, including «hot flashes».
Iron reduces the risk of iron deficiency anemia and menopausal symptoms such as fatigue and muscle weakness.
Vitamin D regulates calcium and phosphorus metabolism, prevents the development of osteoporosis.
Recommendations for use (prevention and complex therapy):
Method of application in complex therapy:
Adults take one capsule а day for 1 month, 30 minutes after a meal, with plenty of water. It is allowed to take the product for a longer period of time up to 2-3 months for the prevention and normalization of ovarian functions.
To intensify the therapeutic effect, it is recommended to combine the bioregulator with other My Real Way peptide-polysaccharide complexes and peptide bioregulators, depending on the pathology.
Contraindications:
Increased individual sensitivity to the components; pregnancy and breast-feeding
IMPORTANT! Peptide bioregulator MenoTIDE PLUS for the health of the female body during menopause acts as an additional prophylactic product in combination with the main course of therapy prescribed by the attending physician.
1 capsule |
NRVs * |
|
Vitamin C |
80 mg |
100 % (NRVs 80 mg.) |
Zinc |
5 mg |
50 % (NRVs 10 mg.) |
Iron |
7 mg |
50 % (NRVs 14 mg.) |
Vitamin E |
6 mg. |
50 % (NRVs 12 mg.) |
Vitamin A |
800 µg. |
100 % (NRVs 800 µg.) |
Vitamin D |
5 µg. |
100 % (NRVs 5 µg.) |
Peptide complex NH, L-phenylalanine, L-threonine, L-tryptophan |
120 mg |
- |
Red clover (Trifolium pratense L.) dry extract |
50 mg |
- |
* NRVs - nutrient reference values
To enhance the therapeutic effect, it is recommended to combine the bioregulator with other My Real Way peptide bioregulators and peptide-polysaccharide complexes depending on the pathology.
Restoration of hormonal levels, the work of the female reproductive and nervous systems, vaso-motor and psycho emotional disorders (hot flashes, night sweats, heart attacks, irritability, drowsiness, weakness, anxiety)
MenoTIDE PLUS |
restores the work of the female reproductive system |
CardioTIDE PLUS |
supports the functional activity of the cardiovascular system |
NervesTIDE PLUS |
normalizes the regulatory function of the central and peripheral nervous system |
Restoration of hormonal levels, the work of the female reproductive system, prevention of complications of menopause – atonic bladder
MenoTIDE PLUS |
restores the work of the female reproductive system |
UrinaTIDE PLUS |
normalizes urination processes |
Prevention of premature aging and strengthening of women's health, restoration of skin structure and functions
MenoTIDE PLUS |
prevention of premature aging and strengthening of women's health |
SkinTIDE PLUS |
restoration of skin structure and functions |
ThyroidTIDE PLUS |
normalization of thyroid functions |
Prevention of premature aging and strengthening of women's health, restoration hair and nails structures
MenoTIDE PLUS |
prevention of premature aging and strengthening of women's health |
HairTIDE PLUS |
restoration of hair and nails structure |
ParathyroidTIDE PLUS |
normalization of parathyroid functions |
Age-related changes in the regulation of calcium metabolism by the parathyroid glands, prevention of senile osteoporosis, fractures in elderly women
MenoTIDE PLUS |
prevention of premature aging and strengthening of women's health |
ParathyroidTIDE PLUS |
normalization of parathyroid functions |
BoneTIDE PLUS |
improvement of recovery processes in bone tissue. Restoring of calcium, magnesium and vitamin D3 deficiencies. |
Breast cancer
Agaricus blazei (Murill) |
anti-tumor action |
MenoTIDE PLUS after menopause (1 year after the last periods) |
improvement of the female reproductive system in menopause |
Cervical and breast cancer
Antrodia Camphorata | anti-tumor action |
MenoTIDE PLUS | restoration and improvement of the female reproductive system, reducing the activity of the inflammatory process. |
The effectiveness of the multi-component peptide bioregulator Bone-marrowTIDE PLUS for the bone marrow was evaluated based on the dynamics of patients’ complaints with IDA (iron deficiency anemia). General weakness, fatigue, sweating, dizziness, noise in the ears and head, dry skin, delamination and brittle nails were studied. Also, general clinical study of blood, urine, biochemical blood test, esophagogastroduodenoscopy (EGD) and fecal occult blood tests were conducted. There were 13 patients in the main group and 13 patients in the control group, ages 52-77.
There were 12 patients who had previously received intermittent iron supplements or some other medical drug therapy. However, this happened uncontrollably, and it is impossible to judge its effectiveness. Patients in the control group received treatment using conventional means. In addition to the standard medical drugs, the main group was prescribed to take multi-component peptide bioregulator Bone-marrowTIDE PLUS, 2 capsules daily for 30-45 days, depending on the severity of the pathological process.
It was established that the use of the multi-component peptide bioregulator Bone-marrowTIDE PLUS in all patients with IDA contributed to a decrease in the clinical development of the disease, improvement and stabilization of general clinical and biochemical blood parameters. The increase in hemoglobin level averaged 24.3 +6.7 g/l, such indicators as microcytosis, aniso- and poikilocytosis improved, and the index of non-hemoglobin iron and ferritin have increased. After a long-term daily complex intake (more than 30 days), the main group showed normalization of the above biochemical parameters in half of the patients. Compared to the control group, the regression of the clinical symptoms in patients was faster (by 3.1+1.4 days on average). According to the results of EFGDS, erosive processes in the stomach were detected in 2 patients in the main group and in 2 patients in the control group. When re-examination was performed on the 20th-24th day after the therapy, no erosions were detected.
A more stable and pronounced effect of improving blood parameters was observed with a more extended intake of the multi-component peptide bioregulator Bone-marrowTIDE PLUS for 40-45 days, which allows us to conclude the dependence of the clinical effect on the complex intake duration. In the process of monitoring patients who received the multi-component peptide bioregulator Bone-marrowTIDE PLUS as part of complex therapy, no side effects, complications or product dependence were detected.
The study was conducted in 2017 by certified specialists from the Department of Restorative Medicine and Nutrition of the European Scientific Society at the Academy of Natural Sciences (Hannover Germany).